Nanjing Bioheng Biotech Co., Ltd.

Nanjing Bioheng Biotech Co., Ltd. is a Chinese biotech company with limited public information available, making due diligence challenging for potential US partners. The company appears to be a smaller, private biotech entity without significant reported pipeline activities or recent deal-making history. While currently clear of BIOSECURE designation, the lack of transparency around corporate structure and operations presents elevated compliance monitoring requirements. US BD teams should proceed with heightened due diligence given the information gaps.

Structure: Corporate structure details are not publicly available, creating uncertainty around potential VIE arrangements or holding company layers typical of Chinese biotech entities. The lack of subsidiary information and ownership transparency will require extensive due diligence to map actual corporate structure and control mechanisms.